Scientific article
Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onset
ContributorsAltomare, Daniele; Ferrari, Clarissa; Caroli, Anna; Galluzzi, Samantha; Prestia, Annapaola; van der Flier, Wiesje M; Ossenkoppele, Rik; Van Berckel, Bart; Barkhof, Frederik; Teunissen, Charlotte E; Wall, Anders; Carter, Stephen F; Schöll, Michael; Choo, I L Han; Grimmer, Timo; Redolfi, Alberto; Nordberg, Agneta; Scheltens, Philip; Drzezga, Alexander; Frisoni, Giovanni; Alzheimer's Disease Neuroimaging Initiative
Published inJournal of Neurology, vol. 266, no. 10, p. 2535-2545
Publication date2019
Abstract
Keywords
- Age of Onset
- Aged
- Aged, 80 and over
- Alzheimer Disease/diagnosis/metabolism/pathology/physiopathology
- Amyloid beta-Peptides/metabolism
- Biomarkers/metabolism
- Cerebral Cortex/diagnostic imaging/metabolism/pathology
- Cognitive Dysfunction/diagnosis/metabolism/pathology/physiopathology
- Datasets as Topic
- Disease Progression
- Female
- Fluorodeoxyglucose F18
- Follow-Up Studies
- Hippocampus/diagnostic imaging/metabolism/pathology
- Humans
- Magnetic Resonance Imaging/standards
- Male
- Middle Aged
- Peptide Fragments/metabolism
- Positron-Emission Tomography/standards
- Predictive Value of Tests
- Prognosis
- tau Proteins/metabolism
Affiliation entities
Research groups
Citation (ISO format)
ALTOMARE, Daniele et al. Prognostic value of Alzheimer’s biomarkers in mild cognitive impairment: the effect of age at onset. In: Journal of Neurology, 2019, vol. 266, n° 10, p. 2535–2545. doi: 10.1007/s00415-019-09441-7
Main files (1)
Article (Published version)
Secondary files (1)
Identifiers
- PID : unige:138781
- DOI : 10.1007/s00415-019-09441-7
- PMID : 31267207
ISSN of the journal0340-5354
